SLS
SELLAS Life Sciences Group, Inc. Common StockstockNASDAQ
σellas life sciences is a healthcare-oriented global group of companies with a unique and innovative vision, which is ambitious, yet clear: to practice the medicine of tomorrow, today. in other words, we incorporate innovation throughout all our activities aiming at breakthroughs that will have a significant impact on the thinking and practicing of healthcare worldwide. our international team of acknowledged scientists, doctors and health professionals along with a seasoned and highly experienced pharmaceutical executive management form the core of σellas. we strive to improve patients' quality of life through developing and commercializing cutting-edge drugs, medical devices and innovative therapies.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 8.37 | 2026-11-10 | +131.03% | 1.732 |
| 1M | 9.98 | 2026-10-16 | +93.76% | 2.769 |
| 3M | 13.00 | 2026-08-17 | +48.75% | 2.430 |
| 6M | 7.29 | 2026-05-18 | +165.26% | 2.368 |
| 1Y | 1.41 | 2025-11-17 | +1271.44% | 2.285 |
| 2Y | 1.29 | 2024-11-18 | +1399.02% | — |
| 5Y | 7.07 | 2021-11-17 | +173.51% | 1.247 |
SELLAS Life Sciences Group, Inc. Common Stock (NASDAQ:SLS) stock price today is $19.34, and today's volume is 75,744,205. SLS is up 158.866% today. The 30 day average volume is 6.99M. SLS market cap is $3.94B with 203.86M shares outstanding.